Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021481
Company: ROCHE
Company: ROCHE
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
FUZEON | ENFUVIRTIDE | 90MG/VIAL | INJECTABLE;SUBCUTANEOUS | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
03/13/2003 | ORIG-1 | Approval | Type 1 - New Molecular Entity | PRIORITY |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021481lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/21481ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/021481_fuzeon_review.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
08/15/2019 | SUPPL-33 | Labeling-Patient Package Insert, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021481s033lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021481Orig1s033ltr.pdf | |
12/27/2018 | SUPPL-32 | Labeling-Patient Package Insert, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021481s032lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021481Orig1s032ltr.pdf | |
12/02/2015 | SUPPL-30 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021481s030lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/021481Orig1s030ltr.pdf | |
06/19/2015 | SUPPL-29 | Manufacturing (CMC) |
Label is not available on this site. |
||
10/31/2013 | SUPPL-27 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021481s027lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/021481Orig1s027ltr.pdf | |
03/13/2013 | SUPPL-26 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/10/2012 | SUPPL-25 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021481s025lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/021481Orig1s025ltr.pdf | |
09/22/2014 | SUPPL-21 | Manufacturing (CMC) |
Label is not available on this site. |
||
04/28/2011 | SUPPL-20 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021481s020lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/021481s020ltr.pdf | |
12/22/2009 | SUPPL-17 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021481s017lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2009/021481s017ltr.pdf | |
12/16/2008 | SUPPL-15 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/021481s015ltr.pdf |
12/20/2006 | SUPPL-12 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021481s012lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021481s012ltr.pdf | |
01/19/2007 | SUPPL-11 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021481s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/021481s011ltr.pdf | |
09/29/2006 | SUPPL-10 | Efficacy-Labeling Change With Clinical Data |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021481s010lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2006/021481s010LTR.pdf | |
08/12/2005 | SUPPL-7 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021481s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021481s007ltr.pdf | |
06/29/2005 | SUPPL-6 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021481s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021481s006ltr.pdf | |
10/15/2004 | SUPPL-2 | Efficacy-Accelerated Approval |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21481s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/21481s002ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
08/15/2019 | SUPPL-33 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021481s033lbl.pdf | |
08/15/2019 | SUPPL-33 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021481s033lbl.pdf | |
12/27/2018 | SUPPL-32 | Labeling-Patient Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021481s032lbl.pdf | |
12/27/2018 | SUPPL-32 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021481s032lbl.pdf | |
12/02/2015 | SUPPL-30 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021481s030lbl.pdf | |
10/31/2013 | SUPPL-27 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021481s027lbl.pdf | |
08/10/2012 | SUPPL-25 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021481s025lbl.pdf | |
04/28/2011 | SUPPL-20 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021481s020lbl.pdf | |
12/22/2009 | SUPPL-17 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021481s017lbl.pdf | |
01/19/2007 | SUPPL-11 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021481s011lbl.pdf | |
12/20/2006 | SUPPL-12 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021481s012lbl.pdf | |
09/29/2006 | SUPPL-10 | Efficacy-Labeling Change With Clinical Data | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2006/021481s010lbl.pdf | |
08/12/2005 | SUPPL-7 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021481s007lbl.pdf | |
06/29/2005 | SUPPL-6 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021481s006lbl.pdf | |
10/15/2004 | SUPPL-2 | Efficacy-Accelerated Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/21481s002lbl.pdf | |
03/13/2003 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/021481lbl.pdf |